Breast cancer organoid study for tumor analysis
Part of Cancer, Skin clinical trials.
This study is testing a new way to understand your breast cancer by growing tiny tumor samples (called organoids) in the lab. It will help researchers learn more about your cancer type and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with newly diagnosed breast cancer that is at least 1.5 cm in size.
- Your doctor has scheduled surgery to remove the tumor.
- You are between 18 and 70 years old.
- You are not pregnant when diagnosed with breast cancer.
- You have not received chemotherapy or other drugs before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a lab-grown mini-tumor (organoid) from your biopsy to test which chemotherapy drugs work best for your cancer before you have surgery. The goal is to personalize your treatment and improve outcomes.
This study grows mini versions of your breast cancer tumor in the lab to understand why some cancers resist chemotherapy. Researchers use this information to help predict which treatment might work best for you.
This trial builds lab “models” (called organoids) from breast cancer tissue to help researchers study different breast cancer types. You may be able to help by providing consent and meeting the study’s basic cancer and treatment history requirements.
This trial uses fluid from the chest or belly of breast cancer patients to grow tiny tumor models in the lab. These models help doctors find which drugs might work best for each patient.
This study collects tumor-related samples from people with invasive breast cancer who are having surgery after treatment before surgery. Researchers use your samples to create lab models (called PDX and organoids) to help study breast cancer and find better future treatments.
This study collects tumor tissue from breast cancer patients before they start chemotherapy to grow miniature versions of their tumors (organoids) in the lab. The goal is to understand how each tumor responds to treatment, which may help personalize future therapies.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.